Evidence map›Paper›PMID 22832282›Full record

ArticleDrug and alcohol dependence2013

Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone).

M L Miller, K M Creehan, D Angrish, D J Barlow, K L Houseknecht, T J Dickerson, M A Taffe

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Explication of CBDrug and alcohol dependence · 2020
    Article
  11. Lasting effects of repeated ∆British journal of pharmacology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Locomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

M L MillerCommittee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA.
K M Creehan
D Angrish
D J Barlow
K L Houseknecht
T J Dickerson
M A Taffe
Scripps Research Institute · USUniversity of New England · US

Funding

Immunopharmacotherapy for Methamphetamine AddictionR01DA024705 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAFFE, MICHAEL A. · 2008 to 2018
$4.4M
BEHAVIORAL TOXICITY OF MDMA IN RHESUS MONKEYSR01DA018418 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI TAFFE, MICHAEL A. · 2005 to 2009
$2.0M
Determinants of transition states in MDMA self-administrationR01DA024105 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI TAFFE, MICHAEL A. · 2011 to 2015
$1.9M
NIDA NIH HHS DA018418NIDA NIH HHS DA024105NIDA NIH HHS DA024705NIDA NIH HHS R01 DA018418NIDA NIH HHS R01 DA024105NIDA NIH HHS R01 DA024705
6 · The paper itself

Abstract

backgroundThe substituted cathinone compound known as mephedrone (4-methylmethcathinone; 4-MMC) has become popular with recreational users of psychomotor-stimulant compounds. Only recently have the first preclinical studies provided information about this drug in the scientific literature; nevertheless, media reports have led to drug control actions in the UK and across several US states. Rodent studies indicate that 4-MMC exhibits neuropharmacological similarity to 3,4-methylenedioxymethamphetamine (MDMA) and prompt investigation of the thermoregulatory, cardiac and locomotor effects of 4-MMC. This study focuses on the role of ambient temperature, which has been shown to shift the effects of MDMA from hyperthermic to hypothermic.

methodsMale Sprague-Dawley rats were monitored after subcutaneous administration of 4-MMC (1.0-5.6 mg/kg) using an implantable radiotelemetry system under conditions of low (20 °C) and high (30 °C) ambient temperature.

resultsA pharmacokinetic study found a T(max) of 0.25 h and a C(max) of 1206 ng/ml after 5.6 mg/kg 4-MMC. A dose-dependent reduction of body temperature was produced by 4-MMC at 20 °C but there was no temperature change at 30 °C. Increased locomotor activity was observed after 4-MMC administration under both ambient temperatures, however, significantly more activity was observed at 30 °C. Heart rate was slowed by 1.0 and 5.6 mg/kg 4-MMC at 20°C, and was slower in the 30 °C vs. 20 °C condition across all treatments.

conclusionThese results show that the cathinone analog 4-MMC exhibits in vivo thermoregulatory properties that are distinct from those produced by MDMA.

Indexed as

AnimalsBody TemperatureBody Temperature RegulationDose-Response Relationship, DrugHeart RateIllicit DrugsMaleMethamphetamineMotor ActivityRatsRats, Sprague-DawleyTemperatureIllicit DrugsmephedroneMethamphetamine

Identifiers

PMID22832282
PMCPMC3491086
OpenAlexW2002503653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.